Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment.

Wu YH, Huang YF, Chen CC, Huang CY, Chou CY.

Open source

DOI: 10.3389/fphar.2020.00206
Published: 2020-03-03
Container: Front Pharmacol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2020.00206,
  title = {Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment.},
  author = {Wu YH and  Huang YF and  Chen CC and  Huang CY and  Chou CY.},
  year = {2020},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2020.00206},
  url = {https://doi.org/10.3389/fphar.2020.00206}
}

RIS

TY  - JOUR
TI  - Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment.
AU  - Wu YH
AU  -  Huang YF
AU  -  Chen CC
AU  -  Huang CY
AU  -  Chou CY.
PY  - 2020
JO  - Front Pharmacol
DO  - 10.3389/fphar.2020.00206
UR  - https://doi.org/10.3389/fphar.2020.00206
ER  -

APA

YH, W., YF, H., CC, C., CY, H., & CY., C. (2020). Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment.. Front Pharmacol. https://doi.org/10.3389/fphar.2020.00206

Source records

europe-pmc · retrieved 2026-09-26T18:35:16.821Z
doaj · retrieved 2026-09-26T18:35:16.820Z